Detection of human papillomavirus in the oral cavities of persons with Fanconi anemia

Oral Diseases

Volumn 21, Issue 3, 2015, Pages 349-354

  Winer, R L ^a   Huang, C E ^a   Cherne, S ^a   Stern, J E ^a   Butsch Kovacic, M S ^b   Mehta, P A ^b   Sauter, S L ^b   Galloway, D A ^c   Katzenellenbogen, R A ^d,e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Fanconi anemia; Head and neck squamous cell carcinoma; Oral human papillomavirus

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANAL INTERCOURSE; ARTICLE; CHILD; COITUS; CROSS-SECTIONAL STUDY; FANCONI ANEMIA; FEMALE; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; MOUTH HYGIENE; MOUTH INFECTION; ORAL SEX; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; POPULATION; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SEXUAL BEHAVIOR; TOBACCO USE; VIRUS DETECTION; WART VIRUS; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; MOUTH; MOUTH DISEASES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRESCHOOL CHILD; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FANCONI ANEMIA; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOUTH; MOUTH DISEASES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SEX FACTORS; YOUNG ADULT;

EID: 84924976037     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12286     Document Type: Article

References (28)

1. Alter BP, Giri N, Savage SA et al (2010). Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol 150: 179-188.
2. Alter BP, Giri N, Savage SA, Quint WG, de Koning MN, Schiffman M (2013). Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: a search for human papillomavirus. International journal of cancer. Int J Cancer 133: 1513-1515.
3. de Araujo MR, Rubira-Bullen IR, Santos CF et al (2011). High prevalence of oral human papillomavirus infection in Fanconi's anemia patients. Oral Dis 17: 572-576.
4. Bui TC, Markham CM, Ross MW, Mullen PD (2013). Examining the association between oral health and oral HPV infection. Cancer Prev Res 6: 917-924.
5. Chaturvedi AK, Engels EA, Pfeiffer RM et al (2011). Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29: 4294-4301.
6. Chaturvedi AK, Anderson WF, Lortet-Tieulent J et al (2013). Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 31: 4550-4559.
7. Cherne S, Popov V, Feng Q (2012). Protocol for the detection and genotyping of human papillomaviruses using a liquid bead microarray assay. Methods Mol Biol 903: 205-223.
8. Comar M, De Rocco D, Cappelli E et al (2013). Fanconi anemia patients are more susceptible to infection with tumor virus SV40. PLoS One 8: e79683.
9. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML (2009). Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 199: 1263-1269.
10. Edelstein ZR, Schwartz SM, Hawes S et al (2012). Rates and determinants of oral human papillomavirus infection in young men. Sex Transm Dis 39: 860-867.
11. Feng Q, Cherne S, Winer RL et al (2009). Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses. J Clin Microbiol 47: 547-553.
12. Gillison ML, Koch WM, Capone RB et al (2000). Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720.
13. Gillison ML, Broutian T, Pickard RK et al (2012). Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 307: 693-703.
14. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009). Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42: 377-381.
15. Herrero R, Quint W, Hildesheim A et al (2013). Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One 8: e68329.
16. Joseph AW, D'Souza G (2012). Epidemiology of human papillomavirus-related head and neck cancer. Otolaryngol Clin North Am 45: 739-764.
17. Kreimer AR, Alberg AJ, Daniel R et al (2004). Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 189: 686-698.
18. Kreimer AR, Bhatia RK, Messeguer AL, Gonzalez P, Herrero R, Giuliano AR (2010). Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis 37: 386-391.
19. Kutler DI, Wreesmann VB, Goberdhan A et al (2003). Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst 95: 1718-1721.
20. Lubin JH, Purdue M, Kelsey K et al (2009). Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case-control studies. Am J Epidemiol 170: 937-947.
21. Myers KC, Bleesing JJ, Davies SM et al (2011). Impaired immune function in children with Fanconi anaemia. Br J Haematol 154: 234-240.
22. Pickard RK, Xiao W, Broutian TR, He X, Gillison ML (2012). The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years. Sex Transm Dis 39: 559-566.
23. Rosenberg PS, Greene MH, Alter BP (2003). Cancer incidence in persons with Fanconi anemia. Blood 101: 822-826.
24. Rosenberg PS, Socie G, Alter BP, Gluckman E (2005). Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 105: 67-73.
25. Rosenberg PS, Alter BP, Ebell W (2008). Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry. Haematologica 93: 511-517.
26. Schiller JT, Castellsague X, Garland SM (2012). A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 30(Suppl 5): F123-F138.
27. Smith EM, Swarnavel S, Ritchie JM, Wang D, Haugen TH, Turek LP (2007). Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents. Pediatr Infect Dis J 26: 836-840.
28. van Zeeburg HJ, Snijders PJ, Wu T et al (2008). Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst 100: 1649-1653.